LEAP THERAPEUTICS, INC. Annual Return On Equity in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Leap Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2017 to 2023.
  • Leap Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -116 %, a 12.8% increase year-over-year.
  • Leap Therapeutics, Inc. annual Return On Equity for 2023 was -133 %, a 89.5% decline from 2022.
  • Leap Therapeutics, Inc. annual Return On Equity for 2022 was -70.3 %, a 26.8% decline from 2021.
  • Leap Therapeutics, Inc. annual Return On Equity for 2021 was -55.4 %, a 10.6% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -133 -62.9 -89.5% Jan 1, 2023 Dec 31, 2023
2022 -70.3 -14.9 -26.8% Jan 1, 2022 Dec 31, 2022
2021 -55.4 +6.59 +10.6% Jan 1, 2021 Dec 31, 2021
2020 -62 +352 +85% Jan 1, 2020 Dec 31, 2020
2019 -414 -204 -96.9% Jan 1, 2019 Dec 31, 2019
2018 -210 -27.7 -15.2% Jan 1, 2018 Dec 31, 2018
2017 -182 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.